Inventor · disambiguated record
Stewart Abbot
Also filed as: ABBOT STEWART · ABBOT STEWART E
16 granted patents·23 pending applications·79 citations·filing 2007–2023
92Inventor score
Top patents by PatentIndex Score
39 records- 0192US8367409B2Amnion derived adherent cellsANTHROGENESIS CORP·Filed 2009·Granted Feb 5, 2013·29 cites·14 claims
- 0290US10150816B2Chimeric antigen receptorsCELGENE CORP·Filed 2013·Granted Dec 11, 2018·15 cites·10 claims
- 0389US11130820B2Chimeric antigen receptorsCELGENE CORP·Filed 2018·Granted Sep 28, 2021·4 cites·12 claims
- 0488US9255248B2Method of producing erythrocytes without feeder cellsANTHROGENESIS CORP·Filed 2013·Granted Feb 9, 2016·5 cites·12 claims
- 0584US9198938B2Amnion derived adherent cellsANTHROGENESIS CORP·Filed 2012·Granted Dec 1, 2015·7 cites·20 claims
- 0684US8586360B2Method of producing erythrocytes without feeder cellsABBOT STEWART·Filed 2010·Granted Nov 19, 2013·4 cites·14 claims
- 0782US8969315B2Enhancement of placental stem cell potency using modulatory RNA moleculesABBOT STEWART·Filed 2011·Granted Mar 3, 2015·4 cites·8 claims
- 0878US10238690B2Modified T lymphocytes comprising an inducible caspase and methods of apoptosisCELGENE CORP·Filed 2014·Granted Mar 26, 2019·3 cites·12 claims
- 0976US10041043B2Method of producing erythrocytes without feeder cellsCELULARITY INC·Filed 2015·Granted Aug 7, 2018·1 cites·10 claims
- 1075US9254302B2Angiogenesis using placental stem cellsABBOT STEWART·Filed 2011·Granted Feb 9, 2016·3 cites·20 claims
- 1175US2023081199A1Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 1274US9763983B2Natural killer cells from placentaANTHROGENESIS CORP·Filed 2014·Granted Sep 19, 2017·2 cites·20 claims
- 1370US11806365B2Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2021·Granted Nov 7, 2023·0 cites·20 claims
- 1470US10967005B2Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2019·Granted Apr 6, 2021·0 cites·18 claims
- 1568US2022106404A1Chimeric antigen receptorsCELGENE CORP·Filed 2021·Application pending·0 cites
- 1667US11512282B2Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2019·Granted Nov 29, 2022·0 cites·15 claims
- 1766US2021032596A1Method of producing erythrocytesCELULARITY INC·Filed 2020·Application pending·0 cites
- 1864US10329529B2Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2014·Granted Jun 25, 2019·0 cites·17 claims
- 1963US2025345429A1Compositions and methods comprising chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2062US2020407681A1Methods of expanding t cellsCELGENE CORP·Filed 2020·Application pending·0 cites
- 2160US7940978B2Automatic characterization of cellular motionGEN ELECTRIC·Filed 2007·Granted May 10, 2011·2 cites·32 claims
- 2260US2025108069A1Chimeric adaptor polypeptidesADICET THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2358US2016137980A1Methods of expanding t cellsANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 2456US2017240860A1Method of producing erythrocytesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 2555US2017000828A1Enhancement of placental stem cell potency using modulatory rna moleculesANTHROGENESIS CORP·Filed 2016·Application pending·0 cites
- 2651US2015368360A1Modified t lymphocytes having improved specificityANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 2750US2018071343A1Angiogenesis using placental stem cellsABBOT STEWART·Filed 2017·Application pending·0 cites
- 2849US2015118265A1Modified erythrocyte precursor cells and uses thereofANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 2949US2018273640A1Modified t lymphocytes having improved specificityCELGENE CORP·Filed 2018·Application pending·0 cites
- 3048US2016015749A1Engager cells for immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2014·Application pending·0 cites
- 3147US2016106784A1Angiogenesis using placental stem cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 3247US2019117692A1Engager cells for immunotherapyBAYLOR COLLEGE MEDICINE·Filed 2018·Application pending·0 cites
- 3346US2016361366A1Amnion derived adherent cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 3444US2015190434A1Enhancement of placental stem cell potency using modulatory rna moleculesANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
- 3544US2015307879A1Anoikis resistant placental stem cells and uses thereofANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 3641US2015225697A1Natural killer cells and uses thereofLAW ERIC·Filed 2013·Application pending·0 cites
- 3737US2012164114A1Treatment of immune-related diseases and disorders using amnion derived adherent cellsABBOT STEWART·Filed 2011·Application pending·0 cites
- 3836US2012156230A1Treatment of spinal cord injury and traumatic brain injury using placental stem cellsABBOT STEWART·Filed 2011·Application pending·0 cites
- 3936US2012201787A1Treatment of spinal cord injury and traumatic brain injury using amnion derived adherent cellsABBOT STEWART·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →